Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00623480 · ClinicalTrials.gov registry record · Phase 3

Trial to Evaluate the Effect of Secondary Prophylaxis With rFVIII Therapy in Severe Hemophilia A Adult and/or Adolescent Subjects Compared to That of Episodic Treatment

A Phase 3 study of Hemophilia A, sponsored by Bayer.

Completed
Registry status
Phase 3
Development phase
84
Enrollment target
20
Study locations

NCT00623480 is a Phase 3 study of Hemophilia A that has completed, run by Bayer. The registered enrollment target is 84 participants, roughly in line with the 90-participant average among 42 other Hemophilia A trials with a reported enrollment target. The trial reports 20 study locations across 18 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00623480, a Phase 3 study of Hemophilia A, has completed, sponsored by Bayer.

COMPLETED
Registry status
Phase 3
Development phase
84 participants
Enrollment target
20
Study locations

Study Summary

To evaluate the effect of secondary prophylaxis as compared to episodic treatment on bleeding frequency (number of bleeds per year) and on joint damage.

Conditions Studied

Hemophilia A

Interventions

  • BIOLOGICAL Recombinant Factor VIII (Kogenate FS, BAY14-2222)

Study Locations (20)

California

  • - Orange
  • - Sacramento

Illinois

  • - Chicago
  • - Chicago

Arizona

  • - Tucson

Arkansas

  • - Little Rock

Colorado

  • - Aurora

District of Columbia

  • - Washington D.C.

Florida

  • - Orlando

Georgia

  • - Atlanta

Trial Details

FieldValue
Enrollment Target 84 participants
Start Date 2008-03
Est. Completion 2013-11
Phase Phase 3

Sponsor

Bayer

591 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00623480

The ClinicalTrials.gov registry entry for NCT00623480 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 90-participant average among 42 other Hemophilia A trials with a reported enrollment target. The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hemophilia A appearing as the primary indexed condition, and to 1 intervention - of which Recombinant Factor VIII (Kogenate FS, BAY14-2222) is the first listed.

NCT00623480 reports 20 study locations spanning 18 distinct geographic areas - top geographies include California, Illinois, Arizona.

Frequently Asked Questions

What is clinical trial NCT00623480 about?

NCT00623480 is a clinical study titled "Trial to Evaluate the Effect of Secondary Prophylaxis With rFVIII Therapy in Severe Hemophilia A Adult and/or Adolescent Subjects Compared to That of Episodic Treatment". To evaluate the effect of secondary prophylaxis as compared to episodic treatment on bleeding frequency (number of bleeds per year) and on joint damage.

What is the current status of trial NCT00623480?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 84 participants. The study started on 2008-03. Estimated completion is 2013-11.

What conditions does trial NCT00623480 study?

This clinical trial studies the following conditions: Hemophilia A.

What interventions are being tested in trial NCT00623480?

The interventions under investigation include: Recombinant Factor VIII (Kogenate FS, BAY14-2222) (BIOLOGICAL).

Who is sponsoring clinical trial NCT00623480?

This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00623480 being conducted?

This trial has 20 study locations across Arizona, Arkansas, California, Colorado, District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Hemophilia A

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Hemophilia A

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.